Synthego

Vision & Mission

Synthego was founded to revolutionize genome engineering technology, helping translate genomics into the clinic and ultimately making engineered biological therapies accessible to all patients. Synthego’s mission is to enable agile life science research and development from discovery through clinical introduction by providing scientists unprecedented access to advanced genome engineering products at high throughput.

1. Synthego offers a continuum of best-in-class solutions designed for advancing CRISPR therapeutics.

   CRISPR Solutions For Every Milestone! In the rapidly advancing field of CRISPR-based therapeutic development, the transition from Research-Use Only (RUO) to Good Manufacturing Practice (GMP) compliance presents significant challenges. Synthego's innovative solutions are engineered specifically to address these challenges within the CRISPR RUO-to-GMP continuum. Our continuum offers unparalleled scalability, enabling researchers and developers to increase production without compromising quality. By leveraging our extensive technical and regulatory expertise, we help you mitigate the risks of delays that can hinder project timelines. Moreover, we facilitate informed decision-making by offering simplified licensing structures for CRISPR systems, crucial for successful downstream commercialization and clinical trials. With Synthego, you gain a trusted partner poised to elevate your therapeutic development aspirations.